Let's talk about what we know about cosmetic surgery. First, it's costly. It's invasive, leaves scars, and has long recovery times. Cosmetic surgery is mostly for the rich and famous -- not regular ...
Whether you have personal experience with cosmetic surgery or not, this corner of the economy is probably larger than you imagine. Grandview Research recently valued the global cosmetic surgery and ...
InMode's Q4 revenue dropped YOY; management optimistic about new platforms despite industry challenges. High dependence on U.S. revenue from minimally invasive procedures; facing increasing ...
InMode shares experienced a significant drop of 20% in one trading day, but the decline is seen as excessively harsh. InMode's unique product line bridges the gap between surgical procedures and ...
WEST HOLLYWOOD, Calif., June 6, 2018 /PRNewswire/ -- Dr. Jason Emer at Jason Emer, MD, is widely known as one of the most creative and innovative dermatologists today, serving the elite clientele of ...
LOS ANGELES, April 18, 2019 /PRNewswire/ -- Dr. Kian Karimi at REJUVA Medical Aesthetics introduces AccuTite, the smallest minimally-invasive radio-frequency assisted lipolysis tissue remodeling ...
InMode Ltd. recently reaffirmed its revenue guidance for the third quarter and full year 2025, expecting US$92.5 million to US$93.0 million for Q3 and US$365 million to US$375 million for the year, in ...
Analysts' price targets for this stock suggest it could soon put up some big gains. Individual investors who want help picking stocks have more than a few options to choose from, including the ...
TipRanks on MSN
InMode price target lowered to $15 from $16 at Canaccord
Canaccord lowered the firm’s price target on InMode (INMD) to $15 from $16 and keeps a Hold rating on the shares. The firm said they are bullish ...
InMode Ltd. (NASDAQ:INMD) is one of the best undervalued medical device stocks to buy now. In a report released on July 10, Caitlin Cronin from Canaccord Genuity maintained a Hold rating on InMode Ltd ...
InMode machines provide a platform for noninvasive cosmetic procedures. The potential for new market entrants and lack of recurring revenue is concerning. Traditional cosmetic surgery is expensive, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback